|
|
Legal status
Patent in force
| (51) | INT.CL. | A61P 19/02 | (2006.01) |
| A61K 31/663 | (2006.01) |
| (11) | Number of the document | 3206694 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15797421.3 |
| Date of filing the European patent application | 2015-10-15 | |
| (97) | Date of publication of the European application | 2017-08-23 |
| (45) | Date of publication and mention of the grant of the patent | 2020-07-08 |
| (46) | Date of publication of the claims translation | 2020-11-25 |
| (86) | Number | PCT/IB2015/057929 |
| Date | 2015-10-15 |
| (87) | Number | WO 2016/059594 |
| Date | 2016-04-21 |
| (30) | Number | Date | Country code |
| MI20141794 | 2014-10-15 | IT |
| (72) |
MASSIMO, Varenna, IT
|
| (73) |
Abiogen Pharma SpA,
Via Meucci 36, 56121 Ospedaletto (PISA),
IT
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Neridrono rūgšties arba jos druskos naudojimas osteoartrozės gydymui |
| USE OF NERIDRONIC ACID OR OF ITS SALT FOR THE TREATMENT OF OSTEOARTHROSIS |
| Payment date | Validity (years) | Amount | |
| 2025-09-16 | 11 | 289.00 EUR |
| 2026-10-15 |